← Back to headlines




Sam Altman-Backed Retro Biosciences Increases Dosage in Alzheimer's Drug Trial
The longevity biotech startup led by Joe Betts-LaCroix is advancing its clinical testing of an Alzheimer's treatment pill following preliminary results that showed limited efficacy.
26 Aug, 15:51 — 26 Aug, 15:51
Related Stories

Tech Giants Urge Global Cyber Defense Surge Against AI Threats
1h ago

Critics and UN Demand Broader Reforms as Meta Faces Backlash Over Teen Safety Settlement
1h ago

BitGo to Acquire NYDIG’s Institutional Trading Business Amid Crypto Rebound
1h ago
Marvell Shares Slip Despite Beating Forecasts and Raising AI-Driven Guidance
2h ago